Amit Gupta Sells 5,964 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 5,964 shares of the firm’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $21,887.88. Following the completion of the transaction, the chief executive officer now owns 186,904 shares in the company, valued at approximately $685,937.68. This represents a 3.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Amit Gupta also recently made the following trade(s):

• On Thursday, October 24th, Amit Gupta sold 22,607 shares of Cardlytics stock. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95.

Cardlytics Stock Down 8.4 %

Shares of NASDAQ CDLX traded down $0.32 during mid-day trading on Monday, reaching $3.49. 2,033,344 shares of the company’s stock were exchanged, compared to its average volume of 1,212,448. Cardlytics, Inc. has a twelve month low of $2.89 and a twelve month high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The firm has a market capitalization of $177.37 million, a price-to-earnings ratio of -0.57 and a beta of 1.53. The business has a fifty day simple moving average of $3.93 and a 200 day simple moving average of $4.85.

Cardlytics (NASDAQ:CDLX) last posted its earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.18. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The business had revenue of $67.06 million during the quarter, compared to analysts’ expectations of $57.77 million. During the same period in the prior year, the business earned ($0.26) EPS. Cardlytics’s revenue for the quarter was down 15.1% compared to the same quarter last year. As a group, equities analysts expect that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Sanctuary Advisors LLC acquired a new position in Cardlytics in the 3rd quarter worth $82,000. Barclays PLC lifted its holdings in shares of Cardlytics by 223.9% in the third quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after purchasing an additional 40,112 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Cardlytics by 7.5% during the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after buying an additional 73,484 shares during the period. Quadrature Capital Ltd bought a new position in shares of Cardlytics during the third quarter worth about $63,000. Finally, RBF Capital LLC grew its holdings in shares of Cardlytics by 311.9% during the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after buying an additional 369,620 shares in the last quarter. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CDLX has been the topic of a number of recent research reports. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. Evercore ISI started coverage on Cardlytics in a research note on Friday, October 11th. They issued an “in-line” rating and a $4.00 price target for the company. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research note on Thursday, November 7th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Cardlytics currently has an average rating of “Hold” and a consensus target price of $6.92.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.